Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris

NCT01474798 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen Research & Development, LLC